Eagle Bay Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-193
| Closed | -$295 | – | 497 |
|
|
2024
Q4 | $295 | Hold |
193
| – | – | ﹤0.01% | 977 |
|
|
2024
Q3 | $384 | Hold |
193
| – | – | ﹤0.01% | 1320 |
|
|
2024
Q2 | $676 | Hold |
193
| – | – | ﹤0.01% | 951 |
|
|
2024
Q1 | $535 | Hold |
193
| – | – | ﹤0.01% | 943 |
|
|
2023
Q4 | $328 | Hold |
193
| – | – | ﹤0.01% | 805 |
|
|
2023
Q3 | $199 | Hold |
193
| – | – | ﹤0.01% | 830 |
|
|
2023
Q2 | $224 | Hold |
193
| – | – | ﹤0.01% | 820 |
|
|
2023
Q1 | $291 | Hold |
193
| – | – | ﹤0.01% | 885 |
|
|
2022
Q4 | $483 | Hold |
193
| – | – | ﹤0.01% | 869 |
|
|
2022
Q3 | $1K | Hold |
193
| – | – | ﹤0.01% | 826 |
|
|
2022
Q2 | $538 | Buy |
+193
| New | +$538 | ﹤0.01% | 907 |
|
|
2022
Q1 | – | Sell |
-193
| Closed | -$2K | – | 591 |
|
|
2021
Q4 | $2K | Hold |
193
| – | – | ﹤0.01% | 884 |
|
|
2021
Q3 | $2K | Hold |
193
| – | – | ﹤0.01% | 902 |
|
|
2021
Q2 | $3K | Buy |
+193
| New | +$3K | ﹤0.01% | 795 |
|